Molecular mimicry and cancer vaccine development

BACKGROUND: The development of cancer immunotherapeutic strategies relies on the identification and validation of optimal target tumor antigens, which should be tumor-specific as well as able to elicit a swift and potent anti-tumor immune response. The vast majority of such strategies are based on t...

Descripción completa

Detalles Bibliográficos
Autores principales: Tagliamonte, Maria, Cavalluzzo, Beatrice, Mauriello, Angela, Ragone, Concetta, Buonaguro, Franco M., Tornesello, Maria Lina, Buonaguro, Luigi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10131527/
https://www.ncbi.nlm.nih.gov/pubmed/37101139
http://dx.doi.org/10.1186/s12943-023-01776-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10131527/
https://www.ncbi.nlm.nih.gov/pubmed/37101139
http://dx.doi.org/10.1186/s12943-023-01776-0

Ejemplares similares